Breast Implant Settlement Calculator 2026: BIA-ALCL Settlement Amounts & Claim Factors
Curious about BIA-ALCL settlement amounts? The Breast Implant Settlement Calculator helps you organize the details that can affect a claim: a confirmed BIA-ALCL diagnosis, exposure to textured implants, serious complications, explant surgery, revision of a reconstruction, systemic symptoms the FDA has described, medical bills, lost income, and other documented losses.
- Keeps confirmed BIA-ALCL claims apart from systemic-symptom and other complication claims.
- Records the implant maker, model, surface texture, serial or lot number, and recall history.
- Organizes pathology, explant, cancer treatment, reconstruction, and damages records.
- Relies on FDA and federal court sources without presenting allegations as proven causation.
Start Your Breast Implant Claim Estimate
Work through the guided questions using details about your diagnosis, implant history, pathology, treatment, explant or revision surgery, and documented losses.
Who Should Consider a Breast Implant Claim Review?
Every claim turns on its own facts, including the diagnosis, the implant’s texture and model, the manufacturer, pathology results, surgical history, recall status, treatment, damages, evidence of causation, state law, and filing deadlines.
Details That May Justify a Closer Look
- BIA-ALCL confirmed by pathology or cytology
- Past textured breast implants or tissue expanders
- Known maker, model, serial number, or a patient device card
- Explant, capsulectomy, cancer treatment, or reconstruction revision
- Documented medical costs, lost wages, or ongoing monitoring
Situations Needing More Investigation
- Systemic symptoms with no formal BIA-ALCL diagnosis
- Implant maker, model, or surface type unknown
- Implants taken out years ago with gaps in the records
- Symptoms that could have several medical causes
- Uncertain diagnosis, discovery date, or deadline
Illustrative Tiers for Breast Implant Claims
These tiers carry over the broad educational groupings from the earlier version of this calculator. They are Legal Lawsuit’s editorial planning illustrations — not official averages, court grids, manufacturer offers, or guaranteed payments.
Severe Confirmed BIA-ALCL
$500,000–$1M+Confirmed lymphoma with substantial cancer treatment, major surgery, lasting effects, clear implant identification, and significant documented losses.
Editorial illustration only.Serious Implant Complications
$150,000–$500,000Major explant or reconstruction revision, serious complications, solid medical records, and significant costs or lost income.
Editorial illustration only.Documented Systemic Symptoms or Complications
$25,000–$150,000Documented symptoms, treatment, explant history, and measurable effects on daily life, without the proof typical of a confirmed lymphoma claim.
Causation is often more disputed.Uncertain Product, Diagnosis, or Deadline
Case-specificGaps in product history, unknown implant texture, thin medical records, or deadline questions call for an individual review.
No dependable numeric estimate.BIA-ALCL: Diagnosis, Implant Texture & What the FDA Reports
BIA-ALCL is a T-cell lymphoma that may form in the scar capsule or fluid surrounding a breast implant. The FDA says the risk is greater with textured-surface implants than with smooth ones.
The FDA’s current MDR review lists 1,380 BIA-ALCL cases through June 30, 2024, and its earlier death table listed 63 deaths through June 30, 2023. The agency warns that MDR data alone cannot establish true incidence or prove causation in any individual case.
Common Presentation
The FDA encourages patients to talk with a clinician about ongoing swelling, a lump, pain, or other changes near an implant.
Texture Matters
According to the FDA, textured implants carry a higher BIA-ALCL risk than smooth implants.
Diagnosis Evidence
Pathology, cytology, CD30 testing, imaging, and cancer treatment records can be essential.
Breast Implant Illness Symptoms: The FDA’s Position
Systemic symptoms reported to the FDA include tiredness, trouble with memory or focus, joint and muscle pain, hair loss, weight changes, anxiety, and depression.
After removing duplicates, the FDA’s review found 10,318 MDRs meeting its systemic-symptom criteria between January 1, 2008 and June 30, 2024. The agency says it remains unclear what causes these symptoms and how closely they may be tied to implants. BII is not presently a recognized formal diagnosis, and there are no accepted diagnostic criteria for it.
Evidence That Can Strengthen a Breast Implant Claim
- Patient device card listing the maker, model, and serial or lot number
- Operative report from the implant surgery
- Information on surface texture and manufacturer
- Explant, capsulectomy, and reconstruction records
- Pathology, cytology, and CD30/ALK test results when relevant
- Oncology, hematology, and imaging records
- Records from specialists treating systemic symptoms
- Photos and a timeline of symptoms
- Medical bills and out-of-pocket expenses
- Proof of lost wages and reduced earnings
- Costs for therapy, counseling, or caregiving
- Records of scarring, pain, and quality of life
MDL 2921: Allergan BIOCELL Textured Breast Implant Litigation
The U.S. District Court for the District of New Jersey still maintains Master Docket 2:19-md-2921. The court names Judge Brian R. Martinotti and Magistrate Judge Leda Dunn Wettre and points users to PACER for the newest filings.
Being part of MDL 2921 does not establish liability or compensation for any claimant. Product identification, BIOCELL exposure, diagnosis, causation, governing law, and damages are still decided case by case.
Why the 2019 BIOCELL Recall Is Still Relevant
The FDA sought the recall of certain Allergan BIOCELL textured implants and tissue expanders because of BIA-ALCL risk. At that time, the agency said its analysis found the BIA-ALCL risk with Allergan BIOCELL textured implants to be roughly six times that of textured implants sold in the U.S. by other manufacturers.
Because surgery carries its own risks, the FDA did not advise routine removal of textured implants in people without symptoms simply because of the recall.
What Influences BIA-ALCL Settlement Amounts and Other Implant Claims?
Diagnosis Strength
A confirmed BIA-ALCL diagnosis backed by pathology and oncology records differs significantly from a claim based on symptoms alone.
Implant Identification
The maker, model, texture, serial or lot number, and recall status can decide which product allegations apply.
Treatment Burden
Explant surgery, capsulectomy, reconstruction revision, chemotherapy, radiation, and monitoring can add to documented losses.
Economic Damages
Medical costs, missed wages, reduced earning ability, travel, and future care can all affect value.
Personal Impact
Scarring, pain, emotional distress, and long-term limitations may matter where the law allows recovery.
Causation and Legal Risk
Other possible explanations, expert testimony, state law, deadlines, and defenses specific to each defendant can significantly change value.
Deadlines for Breast Implant Lawsuits
No single nationwide statute of limitations covers every breast implant claim. The deadline may depend on state law, the diagnosis, when a possible link was discovered, the explant date, recall information, and other facts.
More Legal Lawsuit Resources
Breast Implant Settlement Calculator: Questions and Answers
What does this calculator estimate?
It arranges your diagnosis, implant type, product details, pathology, treatment, explant history, medical costs, lost income, and other losses into an educational range.
Is BIA-ALCL a type of breast cancer?
No. The FDA classifies BIA-ALCL as a T-cell lymphoma, not a cancer of breast tissue.
Do textured implants carry more risk?
Yes. The FDA says BIA-ALCL risk is higher with textured-surface implants than with smooth-surface implants.
Is breast implant illness an official diagnosis?
The FDA says BII is not currently a recognized formal diagnosis, and its cause is still unclear.
Does the Allergan recall automatically give me a lawsuit?
No. Recall status may be relevant, but a claim still depends on product identification, injury, causation, law, deadlines, and damages.
Does using the calculator make me an attorney’s client?
No. Representation begins only when a licensed attorney accepts your case and you sign an engagement agreement.
Get a Free Breast Implant Case Review
If you were diagnosed with BIA-ALCL or had serious complications from breast implants, use the calculator to organize your records or ask for a confidential screening.
Breast Implant Sources: FDA and Federal Court
FDA — Medical Device Reports on BIA-ALCL
The FDA’s published MDR review, covering 1,380 reported BIA-ALCL cases through June 30, 2024, along with the limits of that data.
View the FDA MDR review →FDA — BIA-ALCL Questions and Answers
FDA information on implant texture, symptoms, risk, and identifying your device.
View the FDA Q&A →FDA — Review of Systemic Symptom (BII) Reports
The FDA’s analysis of systemic-symptom reports and its current position that BII is not a formal diagnosis.
View the FDA systemic-symptom review →FDA — Allergan BIOCELL Recall
The FDA’s 2019 request to recall certain Allergan BIOCELL textured implants and tissue expanders.
View the FDA recall announcement →FDA — Breast Implant Safety Requirements
FDA details on boxed warnings, patient decision checklists, and device cards.
View the FDA safety page →District of New Jersey — MDL 2921
The court’s official page for the Allergan BIOCELL Textured Breast Implant Products Liability Litigation.
View the MDL 2921 page →
